litronesib,
LY2523355,
Litronesib,
910634-41-2,
KF 89617,
UNII-6611F8KYCV,
LY2523355,
KF89617,
6611F8KYCV,
LY-2523355,
(-)-N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethanesulfonamido]methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide,
Litronesib [USAN:INN],
Litronesib (USAN/INN),
LY 2523355,
SCHEMBL368284,
CHEMBL2105661,
ZINC56898863,
AKOS030526983,
CS-5194,
DB11861,
SB18860,
AN-26576,
HY-14846,
D09636,
LY-2523355;KF-89617,
634D412,
(-)-N-{4-(2,2-dimethylpropanoyl)-5-(({(2-(ethylamino)ethyl)sulfonyl}amino)methyl)-5- phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl}-2,2-dimethylpropanamide,
(R)-N-{4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5- phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl}-2,2-dimethyl-propionamiden,
N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-propanamide,
Propanamide, N-(4-(2,2-dimethyl-1-oxopropyl)-5-((((2-(ethylamino)ethyl)sulfonyl) amino)methyl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl)-2,2-dimethyl-, (-)-,
Litronesib [USAN],
D0W9SL,